Your browser does not support JavaScript!
Logo de FierceBiotech

FierceBiotech Source d'actualité

Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Bischofberger-helmed Kronos bags $105M to tackle tough targets

Il y a 3 jours
Kronos Bio has raised $105 million. The series A sets the Norbert Bischofberger-helmed biotech up to advance efforts to hit historically undruggable targets. ...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Eisai’s prototype blood test for Alzheimer’s shows links to CSF amyloid in early disease

Il y a 3 jours
New research from Eisai showed measurable correlations between amyloid biomarkers in the bloodstream and changes in the cerebrospinal fluid, bringing the company a step closer to developing a quick...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

EuroBiotech: More Articles of Note

Il y a 3 jours
In our EuroBiotech roundup this week, Oryzon posts phase 2 Alzheimer’s data, Mereo eyes fast approval and AC Immune advances Lilly-partnered drug....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

EuroBiotech Report—Gilead-Galapagos, Alzheimer's fail, AM-Pharma and Abivax

Il y a 3 jours
In this week's EuroBiotech Report, Gilead and Galapagos ink big deal, Novartis chalks up Alzheimer’s failure and AM-Pharma raises €116 million....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M

Il y a 3 jours
Nearly five years after lung-scarring med Ofev got the FDA nod, its maker wants to get cracking on a successor. Boehringer Ingelheim is licensing an autotaxin inhibitor from Bridge Biotherapeutics...
www.fiercebiotech.com
Charger plus d'actualités

Informations juridiques

SIREN / SIRET USA Washington, DC

Adresse

Washington DC USA- Washington, DC Etats-Unis

Equipes

Je travaille dans cette entreprise